QA: Turning Point Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001595893_2021_Turning_Point_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001595893, Turning Point Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,130,679,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,604,000
3 remainder_Assets 3,430,000
4 LiabilitiesCurrent 24,392,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 73,425,000
9 ResearchAndDevelopmentExpense 113,411,000
10 remainder_Expenses 0
11 remainder_Revenues 29,544,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -62,000
  yvar yval
0 Assets 1,136,713,000
1 Liabilities 24,392,000
2 Expenses 186,836,000
3 Revenues 29,544,000
4 StockholdersEquity 1,112,321,000
5 NetIncome -157,292,000
6 ComprehensiveNetIncome -157,323,000
7 BaseVar 688,773,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.91
9 EconomicCapitalRatio 4.32

Edgar->Model Mapping

Feature Distribution